Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind Study of the Effect of Fish Oil (Eicosapentaenoic Acid and Docosahexanoic Acid) on Lung and Systemic Inflammation in Patients With Acute Lung Injury (ALI)
Conditions
Interventions
Fish oil (eicosapentaenoic acid and docosahexanoic acid)
Locations
5
United States
St. Alphonsus Medical Center
Boise, Idaho, United States
Oregon Health Sciences University
Portland, Oregon, United States
University of Vermont/Fletcher Allen Health Care
Burlington, Vermont, United States
Harborview Medical Center
Seattle, Washington, United States
St. Michael's Hospital
Toronto, Ontario, Canada
Start Date
July 1, 2006
Primary Completion Date
January 1, 2009
Completion Date
August 1, 2009
Last Updated
October 3, 2011
NCT07450846
NCT07414056
NCT06701669
NCT07262541
NCT06750536
NCT07086755
Lead Sponsor
University of Washington
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions